Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa

Background. <br/>As antiretroviral therapy (ART) programs in sub-Saharan Africa mature, increasing numbers of persons with human immunodeficiency virus (HIV) infection will experience treatment failure, and require second- or third-line ART. Data on second-line failure and development of prote...

Full description

Bibliographic Details
Main Authors:	Boender, T, Hamers, R, Ondoa, P, Wellington, M, Chimbetete, C, Siwale, M, Labib Maksimos, E, Balinda, S, Kityo, C, Adeyemo, T, Akanmu, A, Mandaliya, K, Botes, M, Stevens, W, Rinke de Wit, T, Sigaloff, K
Format:	Journal article
Published:	Oxford University Press 2016

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa

Similar Items